NIH OligoTox — Oligonucleotide Toxicity Open Data Phase 2 — $500,000 across challenge phases; Phase 2 share per rules — Deadline Dec 31, 2026

NIH / NCATS is accepting entries or eligible applications for NIH OligoTox — Oligonucleotide Toxicity Open Data Phase 2. Create and publish validated human-cell oligonucleotide toxicity datasets.Advertised award: $500,000 across challenge phases; Phase 2 share per rules. Official cutoff noted as Dec 31, 2026. Eligibility / who can apply: Biomedical research teams; open-data and award eligibility rules apply.Organize…

User Has EarnedSnapshot Pending
Offer-Attributed Earnings$0.00Only qualified transactions linked directly to this source are counted here.
NIH OligoTox — Oligonucleotide Toxicity Open Data Phase 2 — $500,000 across challenge phases; Phase 2 share per rules — Deadline Dec 31, 2026

About This Offer

NIH / NCATS is accepting entries or eligible applications for NIH OligoTox — Oligonucleotide Toxicity Open Data Phase 2. Create and publish validated human-cell oligonucleotide toxicity datasets.

Advertised award: $500,000 across challenge phases; Phase 2 share per rules. Official cutoff noted as Dec 31, 2026. Eligibility / who can apply: Biomedical research teams; open-data and award eligibility rules apply.

Organizer notes: Phase-2 deadline Dec 31 at 11:59 p.m. ET; prior-phase prerequisites to confirm. Review the linked rules and final submission instructions before applying.

Eligibility / Who Can Apply

Biomedical research teams; open-data and award eligibility rules apply.

Relevant Skills / Categories

  • Contest
  • AI Dataset Challenge
  • AI creativity
  • data analysis
  • product development

Deadline: Stage / registration deadline: 2026-12-31; Phase-2 deadline Dec 31 at 11:59 p.m. ET; prior-phase prerequisites to confirm.

\n

Related Discovery Content